Indo Us Bio-Tech logo

Indo Us Bio-Tech

INDOUS NSE

Key Fundamentals

MicrocapAgricultural ProductsFMCG
Market Cap
₹159 Cr
Volatility
Moderate
P/E Ratio
13.68
EBITDA
₹6.90 Cr
Return on Equity
13.15%
Debt to Equity
0.4
Book Value
₹46.15
52W High
₹159
52W Low
₹70

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company has delivered good profit growth of 20.8% CAGR over last 5 years
  • Debtor days have improved from 64.6 to 45.5 days.
  • Company's median sales growth is 20.7% of last 10 years

Weaknesses

1
  • Tax rate seems low

Growth Rate

Revenue Growth
24.88% higher than 3Y
Net Income Growth
4.08% lower than 3Y
Cash Flow Change
—
ROE
-42.73% lower than 3Y
ROCE
-24.74% higher than 3Y
EBITDA Margin (Avg.)
3.44% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
19.14
15.81
22.11
15.77
24.72
22.17
23.56
33.38
30.77
30.85
22.8
26.02
32.99
Expenses
16.15
13.21
17.88
14.79
21.03
17.05
18.02
28.8
25.3
26.69
18.65
22.79
29.02
Operating Profit
2.99
2.6
4.23
0.98
3.69
5.12
5.54
4.58
5.47
4.16
4.15
3.23
3.97
OPM %
15.62%
16.45%
19.13%
6.21%
14.93%
23.09%
23.51%
13.72%
17.78%
13.48%
18.2%
12.41%
12.03%
Other Income
0.03
0
0.08
0.21
0.03
0.02
0.02
0.12
0
0.03
0.01
0.02
0.12
Interest
0.37
0.41
0.37
0.36
0.33
0.52
0.38
0.26
0.45
0.42
0.77
0.6
0.74
Depreciation
0.2
0.21
0.19
0.2
0.2
0.18
0.16
0.56
0.2
0.21
0.22
0.27
0.27
PBT
2.45
1.98
3.75
0.63
3.19
4.44
5.02
3.88
4.82
3.56
3.17
2.38
3.08
Tax %
3.27%
15.66%
1.87%
17.46%
0.63%
2.03%
-0.8%
4.9%
2.49%
3.09%
5.36%
17.23%
1.3%
Net Profit
2.37
1.67
3.68
0.52
3.17
4.36
5.05
3.68
4.7
3.45
3
1.97
3.04
EPS in Rs
1.18
0.83
1.84
0.26
1.58
2.17
2.52
1.84
2.34
1.72
1.5
0.98
1.52
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
20
19
24
29
35
40
39
49
61
73
104
110
113
Expenses
19
19
23
27
32
36
34
42
51
62
85
93
97
Operating Profit
1
0
1
3
3
4
6
7
9
11
19
17
16
OPM %
3.1%
2.6%
5%
9%
10%
10%
14%
14%
15%
15%
18%
15%
14%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
1
1
0
1
1
1
1
2
1
2
3
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
1
PBT
0
0
1
2
3
3
4
5
7
9
17
14
12
Tax %
-92%
-50%
25%
29%
26%
12%
-23%
5%
2%
6%
2%
6%
—
Net Profit
0
0
0
1
2
3
5
5
7
8
16
13
11
EPS in Rs
1.11
0.8
0.89
1.41
1.44
1.74
3.52
2.86
3.6
4.11
8.11
6.54
5.72
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
3
5
6
6
9
10
20
20
20
Reserves
1
2
2
2
9
10
15
30
44
43
58
72
Borrowings
2
5
5
7
6
9
11
12
12
14
15
37
Other Liabilities
3
6
4
6
4
10
11
4
3
7
4
4
Total Liabilities
8
14
13
17
24
35
44
56
69
84
98
133
Fixed Assets
1
1
1
2
1
1
2
6
7
7
10
11
CWIP
0
0
0
0
1
1
2
2
1
4
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7
13
11
16
21
32
39
48
61
74
88
121
Total Assets
8
14
13
17
24
35
44
56
69
84
98
133
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
0
-1
-3
-1
0
3
1
2
1
-13
Investing
—
—
0
0
-3
-1
-2
-5
-7
-3
-1
-2
Financing
—
—
0
1
6
2
1
2
6
1
-1
20
Net Cash Flow
—
—
0
0
0
0
0
0
0
1
-1
6
Free Cash Flow
—
—
0
-1
-4
-1
-2
-1
-1
0
1
-15
CFO/OP
—
—
11
-16
-92
-20
6
47
9
23
9
-71
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
25
107
76
112
94
193
229
152
148
95
53
45
Inventory Days
91
118
92
98
176
751
—
—
—
—
—
—
Days Payable
57
115
64
71
34
667
—
—
—
—
—
—
Cash Conversion Cycle
59
110
104
138
236
276
229
152
148
95
53
45
Working Capital Days
66
33
34
59
129
137
186
257
285
266
247
248
ROCE %
14%
7%
14%
28%
20%
17%
18%
16%
15%
14%
21%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Indo Us Bio-Tech insights

60 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

FIIs0.01%Promot.68.29%Others7.19%Public24.51%As ofJun 2026

Documents

Frequently Asked Questions about Indo Us Bio-Tech

What does Indo US Bio-Tech Ltd do?
Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]
Where is Indo US Bio-Tech Ltd (INDOUS) listed?
Indo US Bio-Tech Ltd trades as INDOUS on the NSE and under code 541304 on the BSE.
Which sector does Indo US Bio-Tech Ltd belong to?
Indo US Bio-Tech Ltd is classified under the FMCG sector, in the Agricultural Products industry.
What is the market capitalisation of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd has a market capitalisation of ₹158.81 Cr, which places it in the Small Cap band.
What is the PE ratio of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd trades at a PE ratio of 13.68, against a book value of ₹46.15 per share.
What is the 52-week high and low of Indo US Bio-Tech Ltd?
Over the last 52 weeks Indo US Bio-Tech Ltd has traded between ₹70 and ₹159.
Does Indo US Bio-Tech Ltd pay dividends?
Indo US Bio-Tech Ltd has a dividend yield of 0.31%.
What is the Return on Equity (ROE) of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd reported a return on equity of 13.15%. Its debt-to-equity ratio is 0.40.

Company Information

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]

Website indousagriseeds.com
CEO Mr. Jagdishkumar Devjibhai Ajudia
Listed 2024-09-27
Face Value ₹ 10
Issued Size 2,00,52,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INDOUS.md for Indo US Bio-Tech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in FMCG → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List